Literature DB >> 2738248

Salivary inhibition of HIV-1 infectivity: functional properties and distribution in men, women, and children.

P C Fox1, A Wolff, C K Yeh, J C Atkinson, B J Baum.   

Abstract

Human salivary gland secretions inhibit infection of human lymphocytes by the human immunodeficiency virus 1 (HIV-1), the causative agent of the acquired immune deficiency syndrome (AIDS). This activity was found in saliva collected directly from the orifice of the major salivary gland ducts and the whole saliva of healthy male volunteers. In the current report, the observations on salivary secretions are expanded to a greater number of individuals, including healthy women and children, and men infected with HIV-1.

Entities:  

Mesh:

Year:  1989        PMID: 2738248     DOI: 10.14219/jada.archive.1989.0165

Source DB:  PubMed          Journal:  J Am Dent Assoc        ISSN: 0002-8177            Impact factor:   3.634


  14 in total

1.  Detection of salivary antibodies in cats infected with feline immunodeficiency virus.

Authors:  A Poli; C Giannelli; M Pistello; L Zaccaro; D Pieracci; M Bendinelli; G Malvaldi
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

Review 2.  Antiviral activities in human saliva.

Authors:  D Malamud; W R Abrams; C A Barber; D Weissman; M Rehtanz; E Golub
Journal:  Adv Dent Res       Date:  2011-04

3.  Enhanced secretory leukocyte protease inhibitor in human immunodeficiency virus type 1-infected patients.

Authors:  A A Baqui; T F Meiller; W A Falkler
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

Review 4.  The mouth: a gateway or a trap for HIV?

Authors:  Daniel Malamud; Sharon M Wahl
Journal:  AIDS       Date:  2010-01-02       Impact factor: 4.177

5.  Comparative investigation of Langerhans' cells and potential receptors for HIV in oral, genitourinary and rectal epithelia.

Authors:  L A Hussain; T Lehner
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

6.  Detection of specific antibodies in gingival crevicular transudate by enzyme-linked immunosorbent assay for diagnosis of human immunodeficiency virus type 1 infection.

Authors:  L E Soto-Ramírez; L Hernández-Gómez; J Sifuentes-Osornio; G Barriga-Angulo; D Duarte de Lima; M López-Portillo; G M Ruiz-Palacios
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

7.  Detection of feline immunodeficiency virus in saliva and plasma by cultivation and polymerase chain reaction.

Authors:  D Matteucci; F Baldinotti; P Mazzetti; M Pistello; P Bandecchi; R Ghilarducci; A Poli; F Tozzini; M Bendinelli
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

8.  Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.

Authors:  T B McNeely; M Dealy; D J Dripps; J M Orenstein; S P Eisenberg; S M Wahl
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

Review 9.  Oral diseases in HIV-1 infection.

Authors:  C E Barr
Journal:  Dysphagia       Date:  1992       Impact factor: 3.438

10.  Inhibitory activity in saliva of cell-to-cell transmission of human T-cell lymphotropic virus type 1 in vitro: evaluation of saliva as an alternative source of transmission.

Authors:  T Yamamoto; K Terada; N Nishida; R Moriuchi; S Shirabe; T Nakamura; Y Tsuji; T Miyamoto; S Katamine
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.